Single-nucleotide-resolution genomic maps of O6-methylguanine from the glioblastoma drug temozolomide
Repository for Publications and Research Data (ETH Zurich) · 27.01.2025
DOI: 10.3929/ethz-b-000718164 ↗Kurz gefasst
Fachartikel in der Zeitschrift Repository for Publications and Research Data (ETH Zurich), erschienen am 27.01.2025. Verfasst von Kubitschek und 11 weiteren Autor:innen.
Abstract (Originalsprache)
Temozolomide kills cancer cells by forming O⁶-methylguanine (O⁶-MeG), which leads to cell cycle arrest and apoptosis. However, O⁶-MeG repair by O⁶-methylguanine-DNA methyltransferase (MGMT) contributes to drug resistance. Characterizing genomic profiles of O⁶-MeG could elucidate how O⁶-MeG accumulation is influenced by repair, but there are no methods to map genomic locations of O⁶-MeG. Here, we developed an immunoprecipitation- and polymerase-stalling-based method, termed O⁶-MeG-seq, to locate O⁶-MeG across the whole genome at single-nucleotide resolution. We analyzed O⁶-MeG formation and repair across sequence contexts and functional genomic regions in relation to MGMT expression in a glioblastoma-derived cell line. O⁶-MeG signatures were highly similar to mutational signatures from patients previously treated with temozolomide. Furthermore, MGMT did not preferentially repair O⁶-MeG with respect to sequence context, chromatin state or gene expression level, however, may protect oncogenes from mutations. Finally, we found an MGMT-independent strand bias in O⁶-MeG accumulation in highly expressed genes. These data provide high resolution insight on how O⁶-MeG formation and repair are impacted by genome structure and nucleotide sequence. Further, O⁶-MeG-seq is expected to enable future studies of DNA modification signatures as diagnostic markers for addressing drug resistance and preventing secondary cancers.
Schlagwörter
Zitieren
APA
Kubitschek, Jasmina, Takhaveev, V., Mingard, C., Rochlitz, M. I., Reinert, P. B., Keller, G., Kloter, T., Cereijo, R. F., Huber, S. M., McKeague, M., & Sturla, S. J. (2025). Single-nucleotide-resolution genomic maps of O6-methylguanine from the glioblastoma drug temozolomide. Repository for Publications and Research Data (ETH Zurich). https://doi.org/10.3929/ethz-b-000718164
Vancouver
Kubitschek, Jasmina, Takhaveev V, Mingard C, Rochlitz MI, Reinert PB, et al. Single-nucleotide-resolution genomic maps of O6-methylguanine from the glioblastoma drug temozolomide. Repository for Publications and Research Data (ETH Zurich). 2025. doi:10.3929/ethz-b-000718164
BibTeX
@article{Kubitschek2025,
author = {Kubitschek and Jasmina and Takhaveev, Vakil and Mingard, Cécile and Rochlitz, Martha I and Reinert, Patricia B. and Keller, Giulia and Kloter, Tom and Cereijo, Raúl Fernández and Huber, Sabrina M. and McKeague, Maureen and Sturla, Shana J.},
title = {Single-nucleotide-resolution genomic maps of O6-methylguanine from the glioblastoma drug temozolomide},
journal = {Repository for Publications and Research Data (ETH Zurich)},
year = {2025},
doi = {10.3929/ethz-b-000718164}
}
EUVIMED